Sleep labs and suppliers across the U.S. are bracing for the economic ripple effects of sweeping new tariffs on imported goods. Consider, for example, a typical sleep diagnostic test. It might consist of a small machine, a box with plastic casing that houses electronics. Many of its components—the plastic or […]
Policy, Legal & Regulatory
Avadel’s LUMRYZ Approval Upheld in Court
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced that, on Friday, June 27, 2025, the U.S. Court of Appeals for the District of Columbia Circuit (the “Appeals Court”) affirmed a prior decision of the U.S. District Court for the District of Columbia (the “District […]
Axsome Drops Sunosi Patent Litigation Against Sandoz Generic
Axsome Therapeutics, Inc. announced that it has reached an agreement with Sandoz Inc. (Sandoz) to dismiss the patent litigation related to Axsome’s product Sunosi® (solriamfetol). The litigation, which was pending in the United States District Court for the District of New Jersey, resulted from submission by Sandoz of an Abbreviated New Drug […]
ŌURA Files ITC Action Against Three Competitors for Patent Infringement
ŌURA, best known as the maker of Oura Ring, announced its recent filing with the United States International Trade Commission (ITC) against Ultrahuman, RingConn, and Circular for infringement on several patents related to the Oura Ring form factor and both internal and external components, including sensor functionality and data processing. […]
Masimo Welcomes Reinstated Apple Watch Ban
Masimo welcomes the Federal Circuit’s ruling to lift the temporary stay on the import ban of certain Apple Watch models. This decision reinstates the U.S. International Trade Commission’s import ban and cease and desist order on Apple watches that were found to infringe Masimo’s patented pulse oximetry technology. “The Federal […]
Potential Apple Watch Ban Over Masimo Pulse Ox Technology Infringement
Masimo announced that the United States International Trade Commission (USITC) has recommended a limited exclusion order for infringing Apple Watches with light-based pulse oximetry functionality. The USITC found that Apple violated U.S. laws by incorporating Masimo’s patented light-based pulse oximetry technology in its products. The exclusion is scheduled to go […]
Vanda Loses Patents on Hetlioz Sleep Drug
Vanda Pharmaceuticals Inc. today responded to the ruling in its Hetlioz® Abbreviated New Drug Application appeal. Today a three-judge panel of the United States Court of Appeals for the Federal Circuit issued a written opinion that affirmed a December 13, 2022, decision of the United States District Court for the District of Delaware, […]
Respironics to Pay Over $24 Million for Alleged False Claims
Respironics Inc. has agreed to pay over $24 million to resolve False Claims Act allegations that it misled federal health care programs by paying kickbacks to DME suppliers. The affected programs were Medicare, Medicaid and TRICARE, which is the health care program for active military and their families. The settlement […]
NYU Accuses Resmed of Patent Breach Over Popular Sleep Apnea Product
According to NYU’s complaint filed in the Southern District of New York, the university sent Resmed chief executive Michael Farrell a letter in early June demanding the health group disable key features of its device within 24 hours. The company did not accede to NYU’s request. Resmed sells a range […]
AASM Establishes Congressional Sleep Health Caucus
The American Academy of Sleep Medicine has established a Congressional Sleep Health Caucus to emphasize the necessity of healthy sleep for optimal health and promote high-quality, patient-centered care for the millions of Americans who have sleep disorders. Congressional caucuses are political groups comprising Senate and House members who periodically meet […]













